Signaling to NF-kappaB: regulation by ubiquitination
- PMID: 20300215
- PMCID: PMC2829959
- DOI: 10.1101/cshperspect.a003350
Signaling to NF-kappaB: regulation by ubiquitination
Abstract
The NF-kappaB pathway is a ubiquitous stress response that activates the NF-kappaB family of transcription factors. Antigen receptors, receptors of the innate immune system, and certain intracellular stressors are potent activators of this pathway. The transcriptional program that is activated is both antiapoptotic and highly proinflammatory. Indeed, any compromise in engagement of the pathway results in immunodeficiency, whereas constitutive activation generates a sustained inflammatory response that may promote malignancy. As such, NF-kappaB activation is under tight regulation by a number of post-translational modifications, including phosphorylation and ubiquitination. This article attempts to synthesize our current knowledge regarding the regulation of NF-kappaB signaling by ubiquitination, specifically highlighting the biochemical basis for both positive and negative feedback loops that function in unison to generate coordinated signals that are essential for the viability of metazoan animals.
Figures





Similar articles
-
Linear ubiquitination-mediated NF-κB regulation and its related disorders.J Biochem. 2013 Oct;154(4):313-23. doi: 10.1093/jb/mvt079. Epub 2013 Aug 21. J Biochem. 2013. PMID: 23969028 Review.
-
Linear ubiquitination: a novel NF-κB regulatory mechanism for inflammatory and immune responses by the LUBAC ubiquitin ligase complex.Endocr J. 2012;59(8):641-52. doi: 10.1507/endocrj.ej12-0148. Epub 2012 May 19. Endocr J. 2012. PMID: 22673407 Review.
-
PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.Front Immunol. 2020 Aug 4;11:1559. doi: 10.3389/fimmu.2020.01559. eCollection 2020. Front Immunol. 2020. PMID: 32849529 Free PMC article.
-
Protein Kinase-Mediated Decision Between the Life and Death.Adv Exp Med Biol. 2021;1275:1-33. doi: 10.1007/978-3-030-49844-3_1. Adv Exp Med Biol. 2021. PMID: 33539010
-
TNFR1-activated NF-κB signal transduction: regulation by the ubiquitin/proteasome system.Curr Opin Chem Biol. 2014 Dec;23:71-7. doi: 10.1016/j.cbpa.2014.10.011. Curr Opin Chem Biol. 2014. PMID: 25461388 Review.
Cited by
-
Probiotics Bacillus licheniformis Improves Intestinal Health of Subclinical Necrotic Enteritis-Challenged Broilers.Front Microbiol. 2021 May 18;12:623739. doi: 10.3389/fmicb.2021.623739. eCollection 2021. Front Microbiol. 2021. PMID: 34084155 Free PMC article.
-
Targeting NF-κB in Hepatic Ischemia-Reperfusion Alleviation: from Signaling Networks to Therapeutic Targeting.Mol Neurobiol. 2024 Jun;61(6):3409-3426. doi: 10.1007/s12035-023-03787-w. Epub 2023 Nov 22. Mol Neurobiol. 2024. PMID: 37991700 Review.
-
Genetic analysis reveals functions of atypical polyubiquitin chains.Elife. 2018 Dec 14;7:e42955. doi: 10.7554/eLife.42955. Elife. 2018. PMID: 30547882 Free PMC article.
-
Patient-Specific Modeling of Diffuse Large B-Cell Lymphoma.Biomedicines. 2021 Nov 10;9(11):1655. doi: 10.3390/biomedicines9111655. Biomedicines. 2021. PMID: 34829885 Free PMC article.
-
Inflammation meets cancer, with NF-κB as the matchmaker.Nat Immunol. 2011 Jul 19;12(8):715-23. doi: 10.1038/ni.2060. Nat Immunol. 2011. PMID: 21772280 Review.
References
-
- Barton GM, Medzhitov R 2004. Toll signaling: RIPping off the TNF pathway. Nat Immunol 5:472–474 - PubMed
-
- Bertrand MJ, Doiron K, Labbe K, Korneluk RG, Barker PA, Saleh M 2009. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 30:789–801 - PubMed
-
- Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ, Barker PA 2008. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 30:689–700 - PubMed
-
- Bhoj VG, Chen ZJ 2009. Ubiquitylation in innate and adaptive immunity. Nature 458:430–437 - PubMed
-
- Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, Hurley P, Chien M, Chai S, Hitotsumatsu O, et al.2004. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5:1052–1060 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials